首页>
外国专利>
High dose solid unit oral pharmaceutical dosage form of amorphous nelfinavir mesylate and process for making same
High dose solid unit oral pharmaceutical dosage form of amorphous nelfinavir mesylate and process for making same
展开▼
机译:无定形甲磺酸奈非那韦的大剂量固体单位口服药物剂型及其制备方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
A solid unit oral pharmaceutical dosage form of amorphous nelfinavir mesylate is provided comprising amorphous nelfinavir mesylate in an amount of from about 400 mg to about 700 mg calculated as nelfinavir base, and a pharmaceutically acceptable water soluble, non-ionic synthetic block copolymer of ethylene oxide and propylene oxide, the copolymer having a melting point of at least about 45° C. and an HLB value at 25° C. of from about 18 to about 29, wherein the copolymer is present from about 40% to about 65% by weight of the nelfinavir mesylate. A hot melt granulation process for making the dosage form is provided.
展开▼